| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.045 | 0.4 |